In addition to their role in regulating tumor progression [33, 34], APLNR is mainly involved in the neuroactive ligand-receptor interaction and vascular development [35, 36], while ANXA2 mainly participates in the modulation of depressive behavior and signal transduction pathways [37, 38]. The gene discussed is ANXA2; the disease is neoplasm.